1015 Capital Partners’s ResMed RMD Stock Holding History

1015 Capital Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$780	Hold	4	–	–	﹤0.01%	501
2026 Q1	$898	Hold	4	–	–	﹤0.01%	446
2025 Q4	$963	Buy	+4	New	+$1.02K	﹤0.01%	449

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

1015 Capital Partners's RMD Position: Q2 2026 in Review

1015 Capital Partners held its ResMed (RMD) position steady in Q2 2026 at 4 shares worth $780. The position accounts for ﹤0.01% of the portfolio, ranked #501.

1015 Capital Partners first reported a position in RMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $963 in Q4 2025. 879 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

1015 Capital Partners held 4 shares of ResMed worth $780 as of Q2 2026.
1015 Capital Partners left its ResMed share count unchanged in Q2 2026.
ResMed made up ﹤0.01% of 1015 Capital Partners's portfolio in Q2 2026, its #501 holding.
1015 Capital Partners first reported a position in ResMed in Q4 2025 and has held it in 3 quarters since.
1015 Capital Partners's ResMed position peaked at $963 in Q4 2025.
879 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on 1015 Capital Partners's 13F filing for Q2 2026, filed 21 Jul 2026.